Switching botulinum toxin A products for patients with upper limb spasticity or cervical dystonia a review of clinical effectiveness
The four Botulinum neurotoxin type A (BoNT-A) products have different complex protein structures and differ in their molecular weights, pharmacologic profiles, and potency. Because each BoNT-A product has a different potency, they are not considered interchangeable by Health Canada and dosages may n...
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
CADTH
2018, February 9, 2018
|
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references